FDA's greenlighting of maternal RSV vaccine represents a major step forward in protecting young babies against the virus
Expecting parents and those with infants have new options to consider to protect against RSV. martin-dm/E+ via Getty ImagesWith the Food and Drug Administration’s Aug. 21, 2023, approval of the first vaccine against respiratory syncytial virus, or RSV, for use during late pregnancy, the U.S. will soon have a major new tool at its disposal to protect infants against the highly contagious virus. RSV is the most common cause of lower respiratory infections in young children and can be especi...
Florm Munoz Annette Regan Drug Administration Aug Baylor College Of Medicine Centers For Disease University Of San Francisco
Source: yahoo.com